Cutler Group LP Kiniksa Pharmaceuticals, Ltd. Transaction History

Cutler Group LP

  • $307 Million
  • Q1 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Jan 18, 2022
SELL
$10.39 - $15.15 $15,585 - $22,725
-1,500 Closed
0 $0
Q3 2021

Oct 26, 2021
SELL
$11.39 - $16.23 $5,695 - $8,115
-500 Reduced 25.0%
1,500 $17,000
Q2 2021

Jul 19, 2021
BUY
$13.22 - $19.09 $7,932 - $11,454
600 Added 42.86%
2,000 $27,000
Q1 2021

Apr 26, 2021
BUY
$16.68 - $23.97 $23,352 - $33,558
1,400 New
1,400 $25,000

Others Institutions Holding KNSA

# of Institutions
8
Shares Held
1.95M
Call Options Held
0
Put Options Held
0
View Full List

About Kiniksa Pharmaceuticals, Ltd.

KNSA Quotes by TradingView
  • Ticker KNSA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 34,470,400
  • Market Cap $698M
  • Description
  • Kiniksa Pharmaceuticals, Ltd., a biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases with significant unmet medical needs worldwide. Its product candidates include ARCALYST, an interleukin-1alpha and interleukin-1beta, for the treatm...
More about KNSA
Track This Portfolio

Track Cutler Group LP Portfolio

Follow Cutler Group LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

News

Stay updated on Cutler Group LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email